Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia

The funding opportunity titled Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia is issued by the Centers for Disease Control and Prevention (CDC), specifically through its Global Health Center and Division of Global HIV and Tuberculosis. The CDC plays a central role in advancing global public health through evidence-based programs, international partnerships, and disease prevention strategies. This opportunity aligns with broader U.S. global health priorities and aims to reduce tuberculosis-related morbidity and mortality in high-burden countries that significantly impact both global and domestic public health outcomes. The primary purpose of this cooperative agreement is to strengthen TB prevention, diagnosis, treatment, and surveillance systems in India, the Philippines, and Vietnam. These countries carry a substantial portion of the global TB burden, including drug-resistant and multidrug-resistant TB cases. The program focuses on improving early detection through innovative screening and diagnostic tools, enhancing treatment outcomes using improved regimens, expanding preventive treatment for high-risk populations, and strengthening surveillance systems for data-driven decision-making. Activities are expected to support the full TB care cascade, from screening to treatment completion. Funding under this opportunity is structured as a cooperative agreement, indicating substantial involvement from CDC throughout the project lifecycle. The expected total funding for the first year is $3,000,000, with an anticipated 1 to 3 awards. Applicants are strongly encouraged to propose projects with a budget of approximately $1,000,000 for one country. The period of performance is five years, consisting of five 12-month budget periods, contingent on funding availability, satisfactory progress, and alignment with federal priorities. Funds must be used for programmatic activities and cannot support research, lobbying, or certain restricted activities. Eligibility for this opportunity is broad and unrestricted, allowing a wide range of domestic and international entities to apply. Eligible applicants include government entities at various levels, nonprofit organizations, academic institutions, for-profit entities, and foreign organizations. However, applicants must implement activities in one of the specified countries and meet country-specific regulatory requirements such as India’s Foreign Contribution Regulation Act or Vietnam’s certification requirements. The program does not require cost sharing or matching funds, although voluntary contributions must be reported if included. The application process requires submission through Grants.gov and includes several components such as a project abstract, project narrative, budget narrative, and supporting attachments like organizational capacity documentation and financial statements. Applicants must also include an evaluation and performance measurement plan, a data management plan, and a detailed work plan. Applications are evaluated based on approach, organizational capacity, and data monitoring and evaluation, with a total possible score of 100 points. Responsiveness criteria must be met for applications to proceed to merit review. The application deadline is June 22, 2026, with submissions due by 11:59 PM Eastern Time. Awards are expected to be issued by September 30, 2026, with notifications provided by the end of August 2026. The program includes extensive reporting requirements, including annual performance reports, financial reports, and evaluation updates. Recipients will work closely with CDC through ongoing monitoring, technical assistance, and performance evaluations to ensure program success and alignment with strategic objectives. This opportunity does not explicitly state recurring cycles and is presented as a new funding announcement. However, it is part of an ongoing global TB initiative, suggesting potential future opportunities depending on funding and program priorities. Applicants are encouraged to ensure timely registration with SAM.gov and Grants.gov prior to submission, as these processes can take several weeks.

Align proposal closely with TB burden in selected country; demonstrate strong partnerships with national health systems; emphasize data-driven approaches and measurable outcomes